Partnership Opportunites

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!

Partner With the AFDD Summit

The Fibrosis biopharma leaders are heavily investing in their early fibrosis pipelines to improve their mechanistic understanding of fibrosis, preclinical modelling and predictive, diagnostics and prognostic assays for more confident translation to the clinic.

By partnering with the 7th Antifibrotic Drug Development forum, unlock unrivalled opportunities to engage with senior discovery, preclinical, biomarker, translational and early clinical fibrosis stakeholders and position your service as the go-to solution in solving the translational gap.

To be amongst our 60+ engaged audience with the likes of Alentis, AstraZeneca, BMS, Genentech, Merck, Johnson & Johnson, Novartis, Novo Nordisk, Pfizer, Regeneron and more, now is the time to capitalize on the booming antifibrotic early pipeline investment.

Experts Need Your Help With:

Harnessing state-of-the-art preclinical models for confident translation to clinic; from precision cut-tissue slices, organoids and spheroids to in vivo modelling

Applying cutting-edge serological, imaging, and AI quantification of fibrogenesis to predict, stage and diagnose disease for greater resolution of fibrosis pathology

Drug discovery and multi-omics to support with mechanistic understanding and novel target ID

Clinical trial design CROs to hone trial strategy and design for regulatory success

And more!